Submitted by Anonymous (not verified) on 24 February 2026 - 13:45
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Date of authorisation: 17/11/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Date of authorisation: 17/11/2025, Status: Authorised